The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / New Tick-Borne Virus Identified in China
Infectious Disease Omics Screening and monitoring

New Tick-Borne Virus Identified in China

Molecular and antibody assays identified ALTNV in patients with fever after tick exposure

10/19/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: New Tick-Borne Virus Identified in China

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: New Tick-Borne Virus Identified in China
Key MechanismsALTNV is a distinct orthonairovirus. Laboratory experiments showed that the Asian longhorned tick (Haemaphysalis longicornis) could transmit the virus to mice.
Target PopulationPatients or participants described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • ALTNV was identified in patients with suspected severe fever with thrombocytopenia syndrome (SFTS) who tested negative for Dabie bandavirus (DBV).
  • Among 3,163 patients with fever and recent tick exposure, 10.4% had ALTNV RNA or immunoglobulin M antibodies; among DBV-negative patients, 15.1% had evidence of ALTNV infection.
  • Among 56 patients infected only with ALTNV, fatigue and gastrointestinal symptoms were common; all recovered without reported lasting complications.
  • Coinfected patients had more frequent respiratory symptoms and kidney impairment than patients with DBV alone, but the study could not determine whether ALTNV contributed to greater severity.
  • ALTNV RNA was detected in 1.29% of 47,428 ticks sampled across 15 provinces; laboratory experiments showed transmission to mice by H. longicornis.

Guideline-Based Recommendations

Diagnosis

  • In the study, laboratory confirmation required positive results from two reverse-transcription quantitative polymerase chain reaction assays targeting different genomic regions, followed by further PCR testing and Sanger sequencing.
  • The study used an enzyme-linked immunosorbent assay to detect ALTNV immunoglobulin M.
  • The authors state that further assay validation is required to establish diagnostic performance.

Management

    Monitoring & Follow-up

      Risks

      • ALTNV and DBV occur in the same regions and can produce similar clinical findings; the source states that specific molecular and antibody tests may be needed to distinguish them.
      • Seven patients coinfected with ALTNV and DBV died; the study could not determine whether ALTNV contributed to greater disease severity.

      Patient & Prescribing Data

      The study screened 3,163 patients with fever and recent tick exposure. It described 56 patients with ALTNV-only infection and 38 with ALTNV and DBV coinfection.

      The article reports no treatment regimen. All 56 patients with ALTNV-only infection recovered without reported lasting complications.

      Clinical Best Practices

      • The study identified ALTNV in patients with fever and recent tick exposure, including patients who tested negative for DBV.
      • The source states that specific molecular and antibody tests may be needed to distinguish ALTNV from DBV; further assay validation is required.

      Related Resources & Content

        This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

        Newsletters

        Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

        Newsletter Signup Image

        Explore More in Pathology

        Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

        False

        Advertisement

        Recommended

        False

        Affiliations:

        Specialties:

        Areas of Expertise:

        Contributions:

        False

        The Pathologist
        Subscribe

        About

        • About Us
        • Work at Conexiant Europe
        • Terms and Conditions
        • Privacy Policy
        • Your Privacy Choices
        • Advertise With Us
        • Contact Us

        Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.